Hashimoto, Naotake

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Ueki, K., Sasako, T., Okazaki, Y., Kato, M., Okahata, S., Katsuyama, H., Haraguchi, M., Morita, A., Ohashi, K., Hara, K., et al. (2017) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 313

Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects

Miyazawa-Hoshimoto, S., Takahashi, K., Bujo, H., Hashimoto, N., & Saito, Y. (2003) · Diabetologia

Adipokines, Inflammation, and Metabolic DiseasesAngiogenesis and VEGF in Cancer

Cited by 254

Bisphenol A affects glucose transport in mouse 3T3‐F442A adipocytes

Sakurai, K., Kawazuma, M., Adachi, T., Harigaya, T., Saito, Y., Hashimoto, N., & Mori, C. (2004) · British Journal of Pharmacology

Effects and risks of endocrine disrupting chemicalsAdipokines, Inflammation, and Metabolic Diseases

Cited by 156

A missense mutation in the CD38 gene, a novel factor for insulin secretion: association with Type II diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro

Yagui, K., Shimada, F., Mimura, M., Hashimoto, N., Suzuki, Y., Tokuyama, Y., Nata, K., Tohgo, A., Ikehata, F., Takasawa, S., et al. (1998) · Diabetologia

Pancreatic function and diabetesCalcium signaling and nucleotide metabolism

Cited by 74